BOSTON, Feb. 27, 2026 /PRNewswire/ -- PTC (Nasdaq: PTC) today announced that it will participate in the following conferences. What: KeyBanc Capital Markets Emerging Technology Summit When: 1x1's on T

PTC's Onshape Launches Cloud-Native Model-Based Definition Capabilities

08:30am, Thursday, 26'th Feb 2026

Introduces the only cloud-native MBD capability built into the core modeling experience, fully integrated within CAD and PDM Creates a single, always-up-to-date product definition by embedding manufac

PTC Therapeutics to Participate at Upcoming Investor Conferences

08:00am, Monday, 23'rd Feb 2026

WARREN, N.J., Feb. 23, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences: TD Cowen 46th Annual Health Care Conferen

PTC Therapeutics: Sephience As A Major Growth Driver

07:26am, Monday, 23'rd Feb 2026

PTC Therapeutics is transitioning its growth engine from legacy drugs to new launches like Sephience, targeting rare genetic diseases with high unmet need. Pipeline catalysts, notably Votoplam for Hun

Aurora Investment Counsel Sells 5,716 Shares of PTC Inc. $PTC

05:07am, Sunday, 22'nd Feb 2026

Aurora Investment Counsel decreased its position in PTC Inc. (NASDAQ: PTC) by 70.5% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).

AI Bust or a Once-in-a-Decade Buying Opportunity for This Software Stock?

12:15am, Friday, 20'th Feb 2026

AI is an opportunity, not a threat, for PTC's business model, and growth in its key metric is set to rebound in the near future. The stock's valuation hasn't been this cheap in a decade.

PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results

04:01pm, Thursday, 19'th Feb 2026

– Full-year 2025 product and royalty revenue of $831M, exceeding guidance – – Strong Sephience™ (sepiapterin) uptake since 2H 2025 launch with fourth quarter and 2025 revenue of $92M and $11

Skandinaviska Enskilda Banken AB publ Boosts Stock Position in PTC Inc. $PTC

04:48am, Wednesday, 18'th Feb 2026

Skandinaviska Enskilda Banken AB publ lifted its stake in PTC Inc. (NASDAQ: PTC) by 8.0% in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The fund ow

PTC Therapeutics Provides Regulatory Update on Translarna™

05:00pm, Thursday, 12'th Feb 2026

WARREN, N.J., Feb. 12, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that it has withdrawn the New Drug Application (NDA) resubmission for Translarna™ (ataluren) for th

PTC FlexPLM to Strengthen SPG Company's Licensed Product Operations

08:30am, Thursday, 12'th Feb 2026

Addresses performance, data consistency, and workflow challenges that slow product development and impact downstream teams Enables faster, more collaborative product execution with a cloud-based PLM

Drake & Associates LLC Buys New Position in PTC Inc. $PTC

05:17am, Thursday, 12'th Feb 2026

Drake and Associates LLC purchased a new position in shares of PTC Inc. (NASDAQ: PTC) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). T

Code Rebel (OTCMKTS:CDRBQ) and PTC (NASDAQ:PTC) Critical Analysis

02:32am, Thursday, 12'th Feb 2026

Code Rebel (OTCMKTS:CDRBQ - Get Free Report) and PTC (NASDAQ: PTC - Get Free Report) are both computer and technology companies, but which is the better business? We will compare the two businesses ba

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by